Transaminase, bactérien à large gamme, recombinant, exprimé en E. coli, poudre lyophilisée , >=5 unités/mg solide

Code: t7684-10mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Transaminase has been used in a study to assess the effect of ischemic preconditioning on pathophysiologic alterations of hemodynamic, biochemical and inflammator...


en savoir plus

Votre prix
$385.70 10MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Transaminase has been used in a study to assess the effect of ischemic preconditioning on pathophysiologic alterations of hemodynamic, biochemical and inflammatory parameters observed during intra-abdominal hypertension. Transaminase levels have also been used in a study to investigate the use of hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.

General description

Increased transaminase activity alters the rate at which precursors of protein are interchanged with carbohydrate intermediates.

Packaging

10 mg in poly bottle

Physical form

Lyophilized powder containing potassium phosphate buffer salts

Unit Definition

One unit will produce 1.0 µmole of oxaloacetate from L-aspartate during the transamination of 2-ketoglutarate per min at pH 7.0 at 25 °C in the presence of pyridoxal phosphate.

formlyophilized powder
Quality Level200
recombinantexpressed in E. coli
specific activity≥5 units/mg solid
storage temp.2-8°C
Ce produit répond aux critères suivants: